UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The complete DNA sequence of vaccinia virus

Virology (New York, N.Y.), 1990-11, Vol.179 (1), p.247-266

1990

Volltextzugriff (PDF)

DNA Prime-Canarypox Boost with Polycistronic Hepatitis C Virus (HCV) Genes Generates Potent Immune Responses to HCV Structural and Nonstructural Proteins

The Journal of infectious diseases, 2000-07, Vol.182 (1), p.18-27

2000

Volltextzugriff (PDF)

Reversal of the interferon-sensitive phenotype of a vaccinia virus lacking E3L by expression of the reovirus S4 gene

Journal of Virology, 1995-01, Vol.69 (1), p.499-505

1995

Volltextzugriff (PDF)

NYVAC: A highly attenuated strain of vaccinia virus

Virology (New York, N.Y.), 1992-05, Vol.188 (1), p.217-232

1992

Volltextzugriff (PDF)

Cloning and expression of foreign genes in vaccinia virus, using a host range selection system

Journal of Virology, 1989-09, Vol.63 (9), p.3829-3836

1989

Volltextzugriff (PDF)

Poxvirus‐based vaccine candidates for cancer, AIDS, and other infectious diseases

Journal of leukocyte biology, 1995-07, Vol.58 (1), p.1-13

1995

Volltextzugriff (PDF)

Vaccinia virus host range genes

Virology (New York, N.Y.), 1990-11, Vol.179 (1), p.276-286

1990

Volltextzugriff (PDF)

Expression in recombinant vaccinia virus of the equine herpesvirus 1 gene encoding glycoprotein gp13 and protection of immunized animals

Journal of Virology, 1989-10, Vol.63 (10), p.4189-4198

1989

Volltextzugriff (PDF)

Recombinant Vaccinia Virus: Immunization against Multiple Pathogens

Science (American Association for the Advancement of Science), 1985-09, Vol.229 (4717), p.981-984

1985

Volltextzugriff (PDF)

Deletion of 55 open reading frames from the termini of vaccinia virus

Virology (New York, N.Y.), 1991, Vol.180 (1), p.406-410

1991

Volltextzugriff (PDF)

DNA Immunization with Hepatitis C Virus (HCV) Polycistronic Genes or Immunization by HCV DNA Priming-Recombinant Canarypox Virus Boosting Induces Immune Responses and Protection from Recombinant HCV-Vaccinia Virus Infection in HLA-A2.1-Transgenic Mice

Journal of Virology, 2003-01, Vol.77 (1), p.382-390

2003

Volltextzugriff (PDF)

Protection of mice and swine from pseudorabies virus conferred by vaccinia virus-based recombinants

Journal of Virology, 1992-06, Vol.66 (6), p.3424-3434

1992

Volltextzugriff (PDF)

Exposure to low infective doses of HCV induces cellular immune responses without consistently detectable viremia or seroconversion in chimpanzees

Virology (New York, N.Y.), 2003-09, Vol.314 (2), p.601-616

2003

Volltextzugriff (PDF)

Host-range restriction of vaccinia virus E3L-specific deletion mutants

Virus genes, 1996, Vol.12 (1), p.89-94

1996

Volltextzugriff (PDF)

DNA prime/canarypox boost—based immunotherapy of chronic hepatitis B virus infection in a chimpanzee

Hepatology (Baltimore, Md.), 2001-02, Vol.33 (2), p.448-454

2001

Volltextzugriff (PDF)

Insertion and deletion mutants of vaccinia virus

Virology (New York, N.Y.), 1986-07, Vol.152 (2), p.285-297

1986

Volltextzugriff (PDF)

Coexpression by vaccinia virus recombinants of equine herpesvirus 1 glycoproteins gp13 and gp14 results in potentiated immunity

Journal of Virology, 1990-05, Vol.64 (5), p.2399-2406

1990

Volltextzugriff (PDF)

[34] Vaccinia virus as an expression vector

Methods in Enzymology, 1987, Vol.153, p.545-563

1987

Volltextzugriff (PDF)

Protection of guinea pigs from primary and recurrent herpes simplex virus (HSV) type 2 cutaneous disease with vaccinia virus recombinants expressing HSV glycoprotein D

The Journal of infectious diseases, 1987-06, Vol.155 (6), p.1188-1197

1987

Volltextzugriff (PDF)

Regulation of expression of herpes simplex virus (HSV) glycoprotein D in vaccinia recombinants affects their ability to protect from cutaneous HSV-2 disease

The Journal of infectious diseases, 1989-04, Vol.159 (4), p.625-634

1989

Volltextzugriff (PDF)

Antibody-dependent cellular cytotoxicity is directed against both the gp120 and gp41 envelope proteins of HIV

AIDS (London), 1989-05, Vol.3 (5), p.273-276

1989

Volltextzugriff (PDF)

Antigen-presenting Capacity of Epidermal Cells Infected with Vaccinia Virus Recombinants Containing the Herpes Simplex Virus Glycoprotein D, and Protective Immunity

Journal of general virology, 1989-09, Vol.70 (9), p.2513-2520

1989

Volltextzugriff (PDF)

Mapping the genes in the terminal redundancy of bacteriophage SPO1 with restriction endonucleases

Journal of Virology, 1985-10, Vol.56 (1), p.40-48

1985

Volltextzugriff (PDF)

Vaccinia virus encodes a protein with similarity to glutaredoxins

Virology (New York, N.Y.), 1991-03, Vol.181 (1), p.378-381

1991

Volltextzugriff (PDF)

Optimization of recombinant vaccinia-based ELISPOT assay

Journal of immunological methods, 2003-12, Vol.283 (1), p.281-289

2003

Volltextzugriff (PDF)

1 – 25 von 43

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(42)
Mit Volltextzugriff
(35)

Publikationsform

Artikel
(43)

Sprache

Englisch
(43)

Erscheinungsjahr

n.n

Thema

Science & Technology
(31)
Life Sciences & Biomedicine
(29)
Animals
(27)
Virology
(24)
Vaccinia Virus - Genetics
(23)
Biological And Medical Sciences
(22)
Fundamental And Applied Biological Sciences. Psychology
(20)
Microbiology
(18)
Vaccinia Virus
(16)
Vaccinia Virus - Immunology
(11)
Mice
(10)
Humans
(9)
Viral Proteins - Genetics
(9)
Base Sequence
(8)
Genes, Viral
(8)
Immunology
(8)
Molecular Sequence Data
(8)
Vaccination
(8)
Viral Envelope Proteins - Genetics
(8)
Immunization
(7)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The complete DNA sequence of vaccinia virus

DNA Prime-Canarypox Boost with Polycistronic Hepatitis C Virus (HCV) Genes Generates Potent Immune Responses to HCV Structural and Nonstructural Proteins

Reversal of the interferon-sensitive phenotype of a vaccinia virus lacking E3L by expression of the reovirus S4 gene

NYVAC: A highly attenuated strain of vaccinia virus

Cloning and expression of foreign genes in vaccinia virus, using a host range selection system

Poxvirus‐based vaccine candidates for cancer, AIDS, and other infectious diseases

Vaccinia virus host range genes

Expression in recombinant vaccinia virus of the equine herpesvirus 1 gene encoding glycoprotein gp13 and protection of immunized animals

Recombinant Vaccinia Virus: Immunization against Multiple Pathogens

Deletion of 55 open reading frames from the termini of vaccinia virus

DNA Immunization with Hepatitis C Virus (HCV) Polycistronic Genes or Immunization by HCV DNA Priming-Recombinant Canarypox Virus Boosting Induces Immune Responses and Protection from Recombinant HCV-Vaccinia Virus Infection in HLA-A2.1-Transgenic Mice

Protection of mice and swine from pseudorabies virus conferred by vaccinia virus-based recombinants

Exposure to low infective doses of HCV induces cellular immune responses without consistently detectable viremia or seroconversion in chimpanzees

Host-range restriction of vaccinia virus E3L-specific deletion mutants

DNA prime/canarypox boost—based immunotherapy of chronic hepatitis B virus infection in a chimpanzee

Insertion and deletion mutants of vaccinia virus

Coexpression by vaccinia virus recombinants of equine herpesvirus 1 glycoproteins gp13 and gp14 results in potentiated immunity

[34] Vaccinia virus as an expression vector

Protection of guinea pigs from primary and recurrent herpes simplex virus (HSV) type 2 cutaneous disease with vaccinia virus recombinants expressing HSV glycoprotein D

Regulation of expression of herpes simplex virus (HSV) glycoprotein D in vaccinia recombinants affects their ability to protect from cutaneous HSV-2 disease

Antibody-dependent cellular cytotoxicity is directed against both the gp120 and gp41 envelope proteins of HIV

Antigen-presenting Capacity of Epidermal Cells Infected with Vaccinia Virus Recombinants Containing the Herpes Simplex Virus Glycoprotein D, and Protective Immunity

Mapping the genes in the terminal redundancy of bacteriophage SPO1 with restriction endonucleases

Vaccinia virus encodes a protein with similarity to glutaredoxins

Optimization of recombinant vaccinia-based ELISPOT assay

Suchergebnisse filtern